Gastrointestinal intolerance and bleeding with non-narcotic analgesics

Area of Science:

• Gastroenterology
• Pharmacology
• Internal Medicine

Background:

• Aspirin and paracetamol (acetaminophen) are widely used analgesics with differing gastrointestinal (GI) effects.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) exhibit a range of GI impacts, with aspirin posing a higher risk for serious GI events.

Purpose of the Study:

• To compare the gastrointestinal effects of aspirin and paracetamol.
• To elucidate the differing mechanisms underlying GI damage by these analgesics.
• To provide guidance on analgesic selection for patients with GI risks.

Main Methods:

• Review of existing literature on aspirin, paracetamol, and NSAID-induced GI effects.
• Analysis of epidemiological data and clinical observations regarding GI haemorrhage and ulceration.
• Examination of pathophysiological mechanisms, including effects on gastric mucosal barrier, prostaglandins, and cellular changes.

Main Results:

• Aspirin is significantly associated with major upper GI haemorrhage and the formation of erosions and ulcers, unlike paracetamol.
• Paracetamol use is not linked to significant GI bleeding or ulceration, even in children.
• Aspirin damages the gastric mucosal barrier and reduces protective prostaglandins, while paracetamol has minimal impact on these parameters.

Conclusions:

• Paracetamol is a safer alternative to aspirin for pain relief, particularly in individuals with a history of or predisposition to GI damage.
• Clinicians must maintain a high index of suspicion for silent GI damage induced by aspirin and other NSAIDs.
• Understanding the distinct GI safety profiles of analgesics is crucial for patient management.